RESUMEN
BACKGROUND: Juvenile onset generalized demodicosis (JOGD) is thought to occur due to immunological abnormalities and is over-represented in pit bull terrier-type dogs. ANIMALS: Twelve pit bull terrier-type dogs with JOGD and 12 age-matched healthy pit bull terrier-type dogs. OBJECTIVE: To investigate immunological differences between age-matched healthy and JOGD pit bull terrier-type dogs by flow cytometry, multiplex, molecular and serological assays. METHODS AND MATERIALS: Flow cytometry quantified B cells expressing MHCII or surface-bound IgG, CD4+ T cells expressing MHCII, CD8 T cells expressing MHCII or CD11a, neutrophil and monocyte markers. Surface expression was quantified by calculating the geometric mean fluorescence index. The Wilcoxon rank sum test was used to compare median results for IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, IL-13, IL-18, FOXP3, monocyte chemoattractant protein-1, GM-CSF, KC, IgE, IgA, IgG, IgM, C-reactive protein, lymphocyte, neutrophil and monocyte in the groups. IFN-gamma, IP-10, IL-15, IL-31 and TNF-alpha also were measured; however, insufficient dogs (<5) had values that were in range of the assay to allow for statistical evaluation. Significance was defined as P < 0.05. RESULTS: Serum concentrations of IL-2, IL-18 and MCP-1 were significantly higher (P = 0.01, P = 0.01, P = 0.04) in the JOGD group. Also, IgA median value was significantly higher (P = 0.002) in pit bull terrier-type dogs with JOGD. Flow cytometry revealed that T-cell, neutrophil and monocyte markers were not different between groups. CONCLUSIONS: Results suggest an appropriate compensatory immune response by pit bull terrier-type dogs in the JOGD group and do not support the explanation of global immune deficiency in these dogs.
Asunto(s)
Enfermedades de los Perros/parasitología , Infestaciones por Ácaros/veterinaria , Factores de Edad , Animales , Linfocitos B/inmunología , Linfocitos T CD4-Positivos/inmunología , Estudios de Casos y Controles , Quimiocina CCL2/sangre , Enfermedades de los Perros/inmunología , Perros , Femenino , Citometría de Flujo/veterinaria , Interleucinas/sangre , Masculino , Infestaciones por Ácaros/inmunología , Infestaciones por Ácaros/parasitología , Ácaros/inmunologíaRESUMEN
BACKGROUND: Hemoplasma species (spp.) commonly cause infections in cats worldwide. However, data on risk factors for infections are limited. The aim of this study was to determine the prevalence of hemoplasma spp. infections in cats in Southern Germany and to assess risk factors associated with infection. RESULTS: DNA was extracted from blood samples of 479 cats presented to different veterinary hospitals for various reasons. DNA of feline hemoplasmas was amplified by use of a previously reported PCR assay. Direct sequencing was used to confirm all purified amplicons and compared to hemoplasma sequences reported in GenBank. Results were evaluated in relation to the age, sex, housing conditions, feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) status of the cats. The overall hemoplasma prevalence rate was 9.4% (45/479; 95% CI: 7.08-12.36). 'Candidatus Mycoplasma (M.) haemominutum' (Mhm) DNA was amplified from 42 samples, M. haemofelis from 2, and M. haemocanis from 1 sample. There was a significantly higher risk of hemoplasma infection in cats from multi-cat households, in outdoor cats, as well as in cats with FIVinfection and in cats with abortive FeLV infection, but not in cats with progressive or regressive FeLV infection. CONCLUSIONS: Mhm infection is common in cats in Southern Germany. Higher prevalence in multi-cat households and associations with FeLV infection likely reflect the potential for direct transmission amongst cats. Outdoor access, male gender, and FIV infection are additional risk factors that might relate to aggressive interactions and exposure to vectors.
Asunto(s)
Enfermedades de los Gatos/microbiología , ADN Bacteriano/genética , Infecciones por Mycoplasma/veterinaria , Mycoplasma/clasificación , Animales , Enfermedades de los Gatos/epidemiología , Gatos , ADN Bacteriano/sangre , ADN Bacteriano/aislamiento & purificación , Femenino , Alemania/epidemiología , Masculino , Mycoplasma/genética , Mycoplasma/aislamiento & purificación , Infecciones por Mycoplasma/epidemiología , Infecciones por Mycoplasma/microbiología , Reacción en Cadena de la Polimerasa/veterinaria , Prevalencia , Factores de RiesgoRESUMEN
In this study, we described the content and characteristics of 40 non-proprietary websites offering information about chronic kidney disease (CKD) and evaluated their information quality using the DISCERN scale and readability using Flesch Reading Ease and Flesch-Kincaid grade level. The areas in which the websites scored the lowest on the DISCERN scale were whether the website discussed knowledge gaps, presented balanced information, and was clear about the information source. Websites that rated higher quality on the DISCERN scale were more difficult to read. The quality and readability of many websites about CKD to be used as meaningful educational resources for patients who desire to learn more about CKD and treatment options remain inadequate.
Asunto(s)
Servicios de Información , Internet , Fallo Renal Crónico , Calibración , Educación Continua en Enfermería , HumanosRESUMEN
BACKGROUND: Feline-associated hemotropic Mycoplasma (hemoplasmas) are believed to be transmitted by two primary mechanisms: (1) direct transmission via fighting and (2) vector-borne transmission by the cat flea (Ctenocephalides felis). While the efficiency of transmission by C. felis appears low, most manuscripts focus on the prevalence of hemoplasmas in wild-caught fleas and report either a very low (< 3%) or a high (> 26%) prevalence. Therefore, we aimed to assess the influence of sample processing and PCR methods on C. felis hemoplasma infection prevalence. METHODS: A systemic review of PubMed articles identified 13 manuscripts (1,531 fleas/flea pools) that met the inclusion criteria (performed PCR for >1 hemoplasma on C. felis collected from cats). Risk of bias was assessed utilizing the ROBINS-E tool. Meta-analysis performed in R of these manuscripts found that not washing samples and a common set of 16S rRNA primers first published in Jensen et al. 2001 were associated with increased hemoplasma prevalence. To evaluate the influence of washing on newly collected fleas, we assessed the hemoplasma status of 20 pools of 5 C. felis each, half of which were washed and half not washed. RESULTS: Flea washing did not influence the detection of hemoplasma but instead amplified Spiroplasma. To assess non-specific amplification with the Jensen et al. 2001 primers, 67 C. felis samples (34% previously reported hemoplasma infected) were subject to PCR and sequencing. By this method, hemoplasma was detected in only 3% of samples. In the remaining "hemoplasma infected" fleas, PCR amplified Spiroplasma or other bacteria. CONCLUSIONS: Therefore, we concluded that hemoplasma infection in C. felis is rare, and future flea prevalence studies should sequence all positive amplicons to validate PCR specificity. Further investigation of alternative methods of feline-associated hemoplasma transmission and the ability of C. felis to maintain hemoplasma infection is necessary.
Asunto(s)
Enfermedades de los Gatos , Ctenocephalides , Infecciones por Mycoplasma , Mycoplasma , Animales , Mycoplasma/aislamiento & purificación , Mycoplasma/genética , Mycoplasma/clasificación , Ctenocephalides/microbiología , Gatos , Enfermedades de los Gatos/parasitología , Enfermedades de los Gatos/microbiología , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Gatos/transmisión , Enfermedades de los Gatos/epidemiología , Infecciones por Mycoplasma/veterinaria , Infecciones por Mycoplasma/diagnóstico , Infecciones por Mycoplasma/epidemiología , Infecciones por Mycoplasma/transmisión , Infecciones por Mycoplasma/microbiología , Infestaciones por Pulgas/veterinaria , Infestaciones por Pulgas/parasitología , Infestaciones por Pulgas/epidemiología , Reacción en Cadena de la Polimerasa , Prevalencia , ARN Ribosómico 16S/genéticaRESUMEN
Thyrotropin-releasing hormone (TRH) stimulation can be used as a test of thyroid function and pituitary thyrotropin (thyroid-stimulating hormone, TSH) reserve, but optimal stimulation testing protocols in cats are unreported. We randomly divided 6 healthy young adult cats into 3 groups of 2 and administered 3 different intravenous doses of TRH (0.01, 0.05, 0.1 mg/kg) at weekly intervals in our crossover study. Serum TSH and thyroxine (T4) concentrations were measured using chemiluminescent immunoassay before, and at 30 and 60 min after, TRH administration. All cats were monitored for 4 h post-TRH administration for side effects. All 3 TRH doses induced significant TSH (0.01 mg/kg, p = 0.001; 0.05 mg/kg, p = 0.002; 0.1 mg/kg, p = 0.006) and total T4 (0.01 mg/kg, p = 0.008; 0.05 mg/kg, p = 0.006; 0.1 mg/kg, p = 0.001) responses. Lower TRH doses (0.01 and 0.05 mg/kg) caused fewer side effects (1 of 6 cats) than did the highest dose (3 of 6 cats), and may be safer in cats than the previously reported higher dose (0.1 mg/kg) of TRH. Our results do not support the use of maropitant to prevent side effects of a TRH stimulation test in cats.
Asunto(s)
Hormona Liberadora de Tirotropina , Tirotropina , Gatos , Animales , Hormona Liberadora de Tirotropina/farmacología , Hormona Liberadora de Tirotropina/fisiología , Tiroxina , Estudios Cruzados , TriyodotironinaRESUMEN
BACKGROUND: Effective immunotherapeutic agents for use in cats are needed to aid in the management of intractable viral diseases, including feline infectious peritonitis (FIP) infection. The objectives of this study were to compare two different immune stimulants for antiviral activity in cats: (1) TLR 2/6-activating compound polyprenyl immunostimulant; (PI) and (2) liposome Toll-like receptor 3/9 agonist complexes (LTCs) to determine relative abilities to stimulate the induction of type I (IFN-α, IFN-ß) and type II (IFN-γ) interferon immune responses in vitro and to study the effects of treatment on immune responses in healthy cats. METHODS: Cytokine and cellular immune responses to PI and LTC were evaluated using peripheral blood mononuclear cells (PBMCs) from healthy cats incubated with LTC and PI at indicated concentrations using reverse transcriptase polymerase chain reaction assays and ELISA assays. The effects of the immune stimulants on inhibiting FIPV replication were assessed using a feline macrophage cell line (fcwf-4). Cytokine and cellular immune responses to PI and LTC were evaluated in blood samples from healthy cats treated with PI and LTC, using reverse transcriptase polymerase chain reaction (RT-PCR) and ELISA assays. RESULTS: In the in vitro studies, both compounds triggered the upregulated expression of IFN-α, IFN-γ, and IL-1ß genes in cat PBMC, whereas treatment with LTC induced significantly greater expression of IFN-α and IFN-γ on Day 1 and IL-1b on Day 3. There was significant protection from FIPV-induced cytopathic effects when fcwf-4 cells were treated with conditioned medium from LTC-activated leukocytes. In the healthy cat study (in vivo), both PI and LTC increased the mRNA signal for IFN-α, IFN-γ, and IL-1ß above baseline at multiple time points with statistically greater increases in the LTC group on either Day 1 (IFN-α, IFN-γ) or Day 3 (IL-1ß). In addition, RANTES increased over time in cats treated with the LTC. CONCLUSIONS: Both LTC and PI protocols induced immune-enhancing effects, suggesting a possible clinical use for the management of chronic infectious diseases like FIP. Activating the TLR 3 and 9 pathways (LTC) induced superior broad interferon production in vitro than the activation of the TLR 2 and 6 pathways (PI).
RESUMEN
BACKGROUND: Immune thrombocytopenia (ITP) is commonly associated with platelet-associated immunoglobulins (PAIg). Demonstration of PAIg can help determine etiologies for thrombocytopenia. In humans, ITP and thrombocytopenia have been associated with various vaccinations and influenza infections, respectively. OBJECTIVES: We aimed to evaluate platelet counts and PAIg in research dogs with H3N2 and in research and client-owned dogs routinely vaccinated for distemper, adenovirus-2, parainfluenza, and parvovirus (DA2PP). The hypotheses were that H3N2 infection but not DA2PP vaccination would decrease platelet counts, and neither would result in the detection of PAIg. METHODS: Three pilot studies. Platelet counts and PAIg, measured by direct flow cytometry as %IgG, were evaluated in eight research Beagles following experimental infection with H3N2 (experiment 1), nine research Beagles vaccinated for DA2PP (experiment 2), and thirty client-owned dogs vaccinated for DA2PP (experiment 3). All animals were considered healthy at the start of the experiments. RESULTS: Transient, self-resolving decreases in platelet counts and increases in %IgG occurred following H3N2 infection, and one dog became thrombocytopenic and positive for PAIg. Following DA2PP vaccination, %IgG increased in research and client-owned dogs, but only one dog was considered positive for PAIg with a concurrent increase in platelet count. Mean PAIg increased from baseline in client-owned dogs following vaccination. CONCLUSIONS: Transient PAIg and thrombocytopenia can occur following H3N2 infection, while routine vaccination for DA2PP in this group of dogs was not associated with the development of thrombocytopenia or clinically relevant formation of PAIg.
Asunto(s)
Enfermedades de los Perros , Gripe Humana , Púrpura Trombocitopénica Idiopática , Trombocitopenia , Humanos , Perros , Animales , Recuento de Plaquetas/veterinaria , Plaquetas , Subtipo H3N2 del Virus de la Influenza A , Gripe Humana/complicaciones , Trombocitopenia/diagnóstico , Trombocitopenia/veterinaria , Púrpura Trombocitopénica Idiopática/diagnóstico , Púrpura Trombocitopénica Idiopática/veterinaria , Inmunoglobulina GRESUMEN
Ocular herpes simplex type 1 (HSV-1) infections can trigger conjunctivitis, keratitis, uveitis, and occasionally retinitis, and is a major cause of blindness worldwide. The infections are lifelong and can often recrudesce during periods of stress or immune suppression. Currently HSV-1 infections of the eye are managed primarily with anti-viral eye drops, which require frequent administration, can cause irritation, and may take weeks for full resolution of symptoms. We therefore evaluated the effectiveness of an ocular immune activating nanoparticle eye drop as a novel approach to treating HSV-1 infection, using a cat feline herpesvirus -1 (FHV-1) ocular infection model. In vitro studies demonstrated significant induction of both type I and II interferon responses by the liposome-dual TLR 3/9 agonist nanoparticles, along with suppression of FHV-1 replication. In cats with naturally occurring eye infections either proven or suspected to involve FHV-1, ocular nanoparticle treated animals experienced resolution of signs within several days of treatment, including resolution of keratitis and corneal ulcers. In a cat model of recrudescent FHV-1 infection, cats treated twice daily with immune nanoparticle eye drops experienced significant lessening of ocular signs of infection and significantly fewer episodes of viral shedding compared to control cats. Treatment was well-tolerated by all cats, without signs of drug-induced ocular irritation. We concluded therefore that non-specific ocular immunotherapy offers significant promise as a novel approach to treatment of HSV-1 and FHV-1 ocular infections.
Asunto(s)
Enfermedades de los Gatos , Infecciones Virales del Ojo , Infecciones por Herpesviridae , Herpesviridae , Queratitis , Gatos , Animales , Infecciones por Herpesviridae/veterinaria , Infecciones Virales del Ojo/diagnóstico , Inmunoterapia , Soluciones Oftálmicas , Enfermedades de los Gatos/tratamiento farmacológicoRESUMEN
Purpose: The purpose of this study was to report intermediate-term outcomes following carpal tunnel release using ultrasound guidance and wide-awake local anesthesia no tourniquet, including a subset of patients with preoperative and postoperative magnetic resonance imaging (MRI). Methods: In this observational study, patients with carpal tunnel syndrome were treated with carpal tunnel release using ultrasound guidance and wide-awake local anesthesia no tourniquet in a procedure room at a single center. Main outcomes were complications; return to activity and work at 2 weeks; Quick Disabilities of the Arm, Shoulder, and Hand and Boston Carpal Tunnel Questionnaire scores through 6 months; and postoperative morphological changes of the transverse carpal ligament, median nerve, and carpal tunnel evaluated using MRI. Results: No complications were reported among 65 patients (68% women, 96 wrists). By 2 weeks, 97% of patients returned to normal activity and 100% returned to work. Statistically significant improvements in Boston Carpal Tunnel Questionnaire symptom severity scale, Boston Carpal Tunnel Questionnaire functional status scale, and Quick Disabilities of the Arm, Shoulder, and Hand scores occurred by the 2-week follow-up interval and persisted at 6 months (all P < .001). Pre- and postoperative MRI scans were available for 13 patients (17 wrists) at the 3-month mean follow-up. Complete transverse carpal ligament transection was documented in all wrists. Key MRI findings included a 22% increase in carpal tunnel cross-sectional area at the hamate (P < .001), a 52% increase in median nerve cross-sectional area at the hamate (P < .001), an 18% reduction in median nerve signal intensity (P = .002), a 38% reduction in the flattening ratio of the median nerve at the hamate (P < .001), a 33% reduction in the flattening ratio of the median nerve at the pisiform (P < .001), a 20% reduction in the flattening ratio of the carpal tunnel at the hamate (P < .001), and a palmar shift of the median nerve relative to the hamate in all cases. Conclusions: Carpal tunnel release using ultrasound guidance using wide-awake local anesthesia no tourniquet in a procedure room setting was safe, effective, and resulted in morphological changes that were consistent with carpal tunnel decompression as demonstrated by MRI. Type of study/level of evidence: Therapeutic IV.
RESUMEN
OBJECTIVE: To assess whether hyperinoculation of cats with a feline herpesvirus-1, calicivirus, and panleukopenia virus (FVRCP) vaccine could be used as a model to study interstitial nephritis and to assess humoral and cell-mediated immune responses toward vaccinal α-enolase. ANIMALS: 6 healthy young adult purpose-bred research cats. PROCEDURES: Baseline renal cortical biopsies, whole blood, serum, and urine were collected prior to administration of a commercial FVRCP parenteral vaccine. Vaccine hyperinoculation was defined as a total of 8 vaccinations given at 2-week intervals over a 14-week period. Blood samples were collected immediately prior to each vaccination, and a second renal biopsy was performed 2 weeks after hyperinoculation (week 16). Renal histopathology, renal α-enolase immunohistochemistry, and assays to detect humoral and cell-mediated immune reactions against Crandell-Rees feline kidney (CRFK) cell lysates and α-enolase were performed. An α-enolase immunoreactivity score for renal tubules and glomeruli based on signal intensity was determined by a blinded pathologist. RESULTS: Hyperinoculation with the vaccine was not associated with clinicopathologic evidence of renal dysfunction, and interstitial nephritis was not recognized by light microscopy in the time studied. The mean serum absorbance values for antibodies against CRFK antigen and α-enolase were significantly (P < 0.001) higher at weeks 4, 8, and 16 versus week 0. Renal tubular and glomerular α-enolase immunoreactivity scores were higher at week 16 compared to baseline. CLINICAL RELEVANCE: Findings suggested that systemic immunological reactions occurred and renal tissues were affected by vaccine hyperinoculation; however, short-term FVRCP vaccine hyperinoculation cannot be used to study interstitial nephritis in cats.
Asunto(s)
Calicivirus Felino , Enfermedades de los Gatos , Herpesviridae , Vacunas Virales , Animales , Anticuerpos Antivirales , Enfermedades de los Gatos/patología , Enfermedades de los Gatos/prevención & control , Gatos , Virus de la Panleucopenia Felina , Riñón , Fosfopiruvato Hidratasa , VaricellovirusRESUMEN
OBJECTIVES: The aim of this study was to evaluate the blood of cats in Colorado, USA, with suspected infectious causes of anemia for the presence of Babesia species and Cytauxzoon felis DNA. Results of PCR testing for other common vector-borne diseases potentially associated with anemia are also reported. METHODS: Samples from 101 cats were tested using a PCR assay that coamplified the DNA of C felis and Babesia species mitochondrial DNA. PCR testing for DNA of hemoplasmas, Bartonella species, Ehrlichia species, Anaplasma species, Neorickettsia risticii and Wolbachia genera was also performed if not carried out previously. RESULTS: Twenty-two cats (21.8%) were positive for DNA of an infectious agent. DNA from hemoplasma species were amplified from 14 cats (13.9%). Bartonella species DNA was amplified from four cats (4%) and Ehrlichia canis, Anaplasma platys, Anaplasma phagocytophilum and Wolbachia genera DNA were amplified from one cat each. Babesia species and C felis mitochondrial DNA were not amplified from any sample. CONCLUSIONS AND RELEVANCE: Based on the results of this study, it does not appear that Babesia species or C felis are clinically relevant in anemic cats in Colorado, USA. For C felis, this suggests that the vector Amblyomma americanum is still uncommon in this geographic area.
RESUMEN
BACKGROUND: Hypovitaminosis D is a risk factor for the development of respiratory infections in humans and repletion can be protective. OBJECTIVES: Determine if serum 25-hydroxyvitamin (OH)D concentrations are lower in shelter dogs and if 25(OH)D concentrations are associated with clinical signs of canine infectious respiratory disease complex (CIRDC) or with time in the shelter. ANIMALS: One hundred forty-six shelter dogs (clinically ill n = 36, apparently healthy n = 110) and 23 nonshelter control dogs. METHODS: Prospective cohort study. Shelter dogs were grouped as clinically ill or apparently healthy based on the presence or absence, respectively, of clinical signs associated with CIRDC. Serum 25(OH)D concentrations were measured with a competitive chemiluminesence immunoassay. Nucleic acids of agents associated with the CIRDC were amplified by polymerase chain reaction assays. RESULTS: The concentration of 25(OH)D was 7.3 ng/mL (4.5-9.9, 95% confidence interval [CI]) lower in dogs with signs of CIRDC than apparently healthy shelter dogs (t(142) = 2.0, P = .04). Dogs positive for DNA of canine herpesvirus (CHV)-1 had serum 25(OH)D concentrations 14.9 ng/mL (-3.7 to 29.6, 95% CI) lower than dogs that were negative (t(137) = 2.0, P = .04). Serum 25(OH)D concentrations in shelter dogs were not different from control dogs (t(45) = -1.4, P = .17). Serum 25(OH)D concentration was not associated with duration of time in the shelter (F(1, 140) = 1.7, P = .2, R2 = 0.01). CONCLUSION AND CLINICAL IMPORTANCE: Vitamin D could have a role in acute respiratory tract infections in shelter dogs.
Asunto(s)
Enfermedades de los Perros , Deficiencia de Vitamina D , Animales , Perros , Estudios Prospectivos , Vitamina D/análogos & derivados , Deficiencia de Vitamina D/veterinariaRESUMEN
Ongoing surveillance of Toxoplasma gondii seroprevalence and exposure risks in owned cats is important to identify effective mechanisms to decrease the prevalence of this global zoonotic parasite. We aimed to determine the seroprevalence of T. gondii and risk factors for seropositivity in owned domestic cats in Australia. Sera, signalment data, postcode, and completed owner-questionnaires surveying diet composition and lifestyle factors were collected for cats presenting to 18 veterinary clinics across Australia. T. gondii-specific IgG was measured by enzyme-linked immunosorbent assay. Data were analyzed using univariable and multivariable logistic regression to evaluate risk factors associated with positive T. gondii IgG serology. Among 417 cats, T. gondii seroprevalence was 39%. More than two-thirds of cats tested (69%) had outdoor access and 59% were fed a diet containing raw meat. Univariable analyses identified, age (>1 year, p < 0.001), a diet containing any raw meat (p = 0.001), raw kangaroo (p = 0.008), raw chicken (p = 0.012), or raw beef (p = 0.017), and hunting (p = 0.049) as risk factors for T. gondii infection. Age (>1 year, odds ratio [OR]: 7.15) and feeding of raw meat (OR: 2.23) remained significant risk factors (p < 0.001) in multivariable analyses. T. gondii seroprevalence did not differ between cats domiciled in urban and semiurban or rural areas. Pet cats in Australia are commonly infected with T. gondii. Feeding raw meat to cats, a common practice in Australia, is associated with T. gondii infection, highlighting the need for education about the health implications for cats from feeding a diet containing raw meat.
Asunto(s)
Enfermedades de los Gatos/parasitología , Toxoplasma , Toxoplasmosis Animal/epidemiología , Animales , Australia/epidemiología , Enfermedades de los Gatos/epidemiología , Gatos , Estudios Transversales , Femenino , Masculino , Propiedad , Vigilancia de la Población , Factores de Riesgo , Estudios SeroepidemiológicosRESUMEN
Two groups of feline panleukopenia virus (FPV), feline calicivirus (FCV), and feline herpesvirus-1 (FHV-1) seronegative cats (five cats per group) were administered one of two modified live feline viral rhinotracheitis, calicivirus, and panleukopenia virus (FVRCP) vaccines and the serological responses to each agent were followed over 28 days. While all cats developed detectable FPV and FCV antibody titers; only two cats developed detectable FHV-1 antibody titers using the criteria described by the testing laboratory. For FPV and FHV-1, there were no differences in seroconversion rates between the cats that were administered the intranasal (IN) FVRCP vaccine and the cats that were administered the parenteral FVRCP vaccine on any day post-inoculation. For FCV, the cats that were administered the IN FVRCP vaccine were more likely to seroconvert on days 10 and 14 when compared to cats that were administered the parenteral FVRCP vaccine.
Asunto(s)
Anticuerpos Antivirales/sangre , Calicivirus Felino/inmunología , Virus de la Panleucopenia Felina/inmunología , Herpesviridae/inmunología , Vacunas Virales/inmunología , Administración Intranasal , Animales , Infecciones por Caliciviridae/prevención & control , Infecciones por Caliciviridae/veterinaria , Enfermedades de los Gatos/prevención & control , Gatos , Panleucopenia Felina/prevención & control , Femenino , Infecciones por Herpesviridae/prevención & control , Infecciones por Herpesviridae/veterinaria , Infusiones Parenterales/veterinaria , Masculino , Organismos Libres de Patógenos Específicos , Vacunas Virales/administración & dosificaciónRESUMEN
The purpose of this study was to determine whether there are associations between Bartonella species antibody (enzyme-linked immunosorbent assay (ELISA) and Western blot (WB)) and polymerase chain reaction assay results in cats with and without fever. Afebrile control cats (39/93; 42.0%) were more likely to have Bartonella species antibodies than cats with fever (29/93; 31.2%). The difference in prevalence of Bartonella species deoxyribonucleic acid (DNA) in blood of cats with fever (14/81; 17.3%) as compared to afebrile control cats (6/81; 7.4%) approached statistical significance (P=0.0571). Bartonella species ELISA or WB results frequently did not correlate to the presence or absence of Bartonella species DNA in blood. The results of this study indicate that in cats, Bartonella species antibody tests cannot predict whether fever is due to Bartonella species infection and should not be used to determine the Bartonella species infection status.
Asunto(s)
Infecciones por Bartonella/veterinaria , Bartonella/aislamiento & purificación , Western Blotting/veterinaria , Enfermedades de los Gatos/epidemiología , Ensayo de Inmunoadsorción Enzimática/veterinaria , Reacción en Cadena de la Polimerasa/veterinaria , Animales , Anticuerpos Antibacterianos/sangre , Bartonella/genética , Bartonella/inmunología , Infecciones por Bartonella/epidemiología , Infecciones por Bartonella/microbiología , Bartonella henselae/genética , Bartonella henselae/inmunología , Bartonella henselae/aislamiento & purificación , Western Blotting/normas , Enfermedades de los Gatos/sangre , Enfermedades de los Gatos/microbiología , Gatos , ADN Bacteriano/sangre , Ensayo de Inmunoadsorción Enzimática/normas , Fiebre/sangre , Fiebre/microbiología , Fiebre/veterinaria , Epítopos Inmunodominantes/inmunología , Inmunoglobulina G/sangre , Reacción en Cadena de la Polimerasa/normas , Valor Predictivo de las Pruebas , PrevalenciaRESUMEN
Rickettsia species antibodies have been detected in some cats but it is unknown whether infected cats develop clinical signs. The prevalence of Rickettsia species deoxyribonucleic acid (DNA) in blood from clinically ill cats has not been determined. The objective of this study was to determine if cats with fever (body temperature >or=102.5 degrees F [39.2 degrees C]) were more likely to have evidence of rickettsial infection than healthy, age-matched, control cats with a body temperature<102.5 degrees F. Rickettsia species polymerase chain reaction (PCR) assays were performed to detect rickettsial DNA extracted from blood (71 paired samples), indirect immunofluorescence assays (IFA) were performed to detect serum antibodies against Rickettsia felis (90 paired samples) and Rickettsia rickettsii (91 paired samples), and the results between pairs were compared. All samples were negative for Rickettsia species DNA. More cats with fever were seropositive for R felis or R rickettsii than control cats, but results were not statistically significant. Results of this pilot study failed to show an association between Rickettsia species DNA or Rickettsia species antibodies and fever.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Enfermedades de los Gatos/sangre , ADN Bacteriano/aislamiento & purificación , Fiebre/veterinaria , Infecciones por Rickettsia/veterinaria , Rickettsia , Animales , Estudios de Casos y Controles , Gatos , Femenino , Fiebre/sangre , Técnica del Anticuerpo Fluorescente Indirecta/veterinaria , Masculino , Proyectos Piloto , Reacción en Cadena de la Polimerasa/veterinaria , Rickettsia/inmunología , Rickettsia/aislamiento & purificación , Infecciones por Rickettsia/sangre , Infecciones por Rickettsia/epidemiología , Rickettsia felis/inmunología , Rickettsia felis/aislamiento & purificación , Rickettsia rickettsii/inmunología , Rickettsia rickettsii/aislamiento & purificación , Estudios SeroepidemiológicosRESUMEN
The purpose of this study was to determine the prevalence of Bartonella species and Rickettsia species DNA in the blood, oral cavity, skin and claw beds of feral cats without evidence of skin disease that were housed in Alabama (n = 24), Florida (n = 27) and Colorado (n = 32). Samples were assessed by use of polymerase chain reaction assays. The Bartonella species IgG prevalence was also determined. While Bartonella species DNA was not amplified from any sample from Colorado cats, it was commonly amplified from blood (56.9%), skin (31.4%), claws (17.6%) and gingiva (17.6%) of the 51 cats housed in Alabama and Florida. All 10 flea groups assessed in this study were infected with a Bartonella species or R. felis. Bartonella species IgG titres did not accurately predict bacteraemia (positive predictive value = 57.1%; negative predictive value = 82.1%). Bartonella species DNA was amplified from blood of cats with and without C. felis. Rickettsia felis DNA was only detected in or on the skin of one cat and the gingiva of an additional cat. It was concluded that cats can be an occupational health risk for veterinarians, particularly in areas with high prevalence of Ctenocephalides felis. Further study is required to determine whether Bartonella species or Rickettsia species infections of cats are associated with dermatological disease. The combination of Bartonella species serological test results with Bartonella species PCR or culture is likely to give the most accurate information concerning the current infection status of individual cats.
Asunto(s)
Bartonella/genética , Bartonella/aislamiento & purificación , Enfermedades de los Gatos/microbiología , ADN Bacteriano/genética , Rickettsia/genética , Rickettsia/aislamiento & purificación , Animales , Infecciones por Bartonella/epidemiología , Infecciones por Bartonella/microbiología , Infecciones por Bartonella/veterinaria , Enfermedades de los Gatos/epidemiología , Gatos , Pezuñas y Garras/microbiología , Boca/microbiología , Infecciones por Rickettsia/epidemiología , Infecciones por Rickettsia/microbiología , Infecciones por Rickettsia/veterinaria , Piel/microbiología , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: Feline herpesvirus-1 (FHV-1) infection can result in serious morbidity and mortality, especially in kittens. Immunotherapy using liposome-toll-like receptor (TLR) ligand complexes (LTC) has been shown to activate innate immune responses. OBJECTIVES: To determine in kittens whether mucosal administration of LTC before FHV-1 inoculation would decrease severity of clinical signs and decrease quantities of FHV-1 DNA in materials collected on oropharyngeal swabs. ANIMALS: Nineteen, 14-week-old, purpose-bred kittens. METHODS: Pilot clinical trial with 2 groups of kittens allocated to either an LTC or control group. The LTC were administered into both nares and the oropharynx of the 12 LTC group kittens, and all 19 kittens were inoculated with FHV-1 24 hours later. Clinical scores were determined daily for 28 days, and oropharyngeal mucosal materials were collected every 7 days to assess FHV-1 DNA quantities for comparison between groups. RESULTS: Conjunctivitis was more common in kittens in the control group on Days 15-28 (P = .01) and Days 1-28 (P = .02). Total respiratory scores were higher in the LTC group on days 15-28 (P = .03). The LTC group had significantly decreased FHV-1 DNA on swabs when compared to the control group on some postinoculation days, using 2 methods of calculation. CONCLUSIONS AND CLINICAL IMPORTANCE: Administration of LTC to kittens was shown to decrease FHV-1 DNA and some manifestations of illness in kittens when administrated 24 hours before inoculation, suggesting clinical benefit.
Asunto(s)
Enfermedades de los Gatos/virología , Infecciones por Herpesviridae/veterinaria , Liposomas/administración & dosificación , Receptores Toll-Like/agonistas , Varicellovirus/inmunología , Animales , Enfermedades de los Gatos/inmunología , Enfermedades de los Gatos/prevención & control , Gatos , ADN Viral/aislamiento & purificación , Femenino , Infecciones por Herpesviridae/inmunología , Infecciones por Herpesviridae/prevención & control , Inmunidad Innata , Masculino , Membrana Mucosa/inmunología , Membrana Mucosa/virología , Proyectos Piloto , Varicellovirus/aislamiento & purificaciónRESUMEN
Gingivostomatitis (GS) is a significant condition in cats because of oral discomfort and associated periodontal disease. Several infectious agents have been associated with the presence of GS, but a causal relationship is unclear. The cats in this study were housed together, had a history of flea exposure, and were vaccinated with a modified live FVRCP product. There were nine cats with active GS and 36 unaffected cats at the time of sample collection. Serum was tested for feline leukemia virus (FeLV) antigen and antibodies against feline immunodeficiency virus, feline calicivirus (FCV), feline herpesvirus 1 (FHV-1), and Bartonella species (enzyme-linked immunosorbent assay and Western blot immunoassay). PCR assays for Bartonella species and FHV-1 and a reverse transcriptase PCR assay for FCV were performed on blood and throat swabs. All cats were negative for FeLV. Assay results failed to correlate to the presence of GS in the group of cats studied.
Asunto(s)
Enfermedades de los Gatos/virología , Gingivitis/veterinaria , Gingivitis/virología , Estomatitis/veterinaria , Estomatitis/virología , Animales , Anticuerpos Antivirales/sangre , Antígenos Virales/aislamiento & purificación , Bartonella/aislamiento & purificación , Calicivirus Felino/aislamiento & purificación , Gatos , Enfermedad Crónica , Coronavirus Felino/aislamiento & purificación , Ensayo de Inmunoadsorción Enzimática , Virus de la Panleucopenia Felina/aislamiento & purificación , Femenino , Herpesviridae/aislamiento & purificación , Virus de la Inmunodeficiencia Felina/aislamiento & purificación , Virus de la Leucemia Felina/aislamiento & purificación , MasculinoRESUMEN
We compared a qualitative in-clinic (IC)-PCR for the detection of Mycoplasma haemofelis DNA with the results of a commercial qualitative laboratory-based, conventional (c)PCR. In order to determine the specificity of both tests, Bartonella spp. samples were included. Forty-three previously tested blood samples with known PCR results for hemoplasmas and Bartonella spp. were selected. The samples were split between 2 laboratories. At the first laboratory, DNA was purified and run on 2 cPCR assays for the detection of hemoplasmas and Bartonella spp. At the second laboratory, DNA was purified using 2 purification protocols and both run in the IC-PCR assay. The cPCR results confirmed that 18 samples were positive for M. haemofelis, 5 for ' Candidatus M. haemominutum', 8 for Bartonella henselae, 2 for Bartonella clarridgeiae, and 10 were negative for both genera. No mixed infections were observed. The IC-PCR assay for the detection of M. haemofelis had a sensitivity of 94.4% and specificity of 96%, when using the same DNA purification method as the first laboratory. Using the second purification method, the sensitivity of the IC-PCR assay was 77.8% and specificity was 96%. Bartonella species were not detected by the IC-PCR M. haemofelis assay. The IC-PCR assay decreased the amount of time to final result compared to a cPCR assay.